25 S&P 500 Stocks Have Doubled in 2026 — Two Are Healthcare Names

Life Science

Investors Worried About Inflation, Healthcare Sector Offers a Safe Haven

Life Science

Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day

Life Science

Novo Nordisk Stock Has Fallen Sharply, Does a Long-Term Opportunity Emerge?

Life Science

HSBC Raises AbbVie Price Target to $315 on Immunology Drug Label Expansions

Life Science

Pfizer’s High Dividend Is Undervalued by the Market, and Investors May Be Facing a Good Opportunity to Position Themselves

Life Science

Curaleaf Sweetens Aurora Cannabis Takeover Bid to $5 a Share

Cannabis

Down 70%, Novo Nordisk Bets $3.9 Billion to Outrun Eli Lilly in the Weight-Loss Race

Life Science

Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track

Life Science

AbbVie vs. Bristol Myers Squibb: A Clash Between Growth Premium and Value Trap

Life Science

Lilly and Viking Just Showed the Obesity Market’s Next Phase — and It’s Not About Pounds

Life Science

Competition Fears Are Overblown, and Eli Lilly’s Growth Engine Remains Strong

Life Science

AstraZeneca to Invest $2 Billion in Summit Therapeutics, Backing China-Licensed Cancer Drug

Life Science

Kodiak Sciences Stock Soars as Trial Data Boosts Market Confidence

Life Science

Summit Secures $2 Billion Investment From AstraZeneca, and the Two Parties Will Jointly Develop Anti-Cancer Drugs

Life Science